BLTE 内幕交易
BLTE 的 SEC Form 4 内幕交易记录
总交易
195
买入
0
买入总额
-
卖出总额
$128.7M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(50) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 126,800 | $177.58 | $22.5M | 2026-08-12 | CEO卖出, 董事卖出 |
| ★★★★★(50) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 136,000 | $178.73 | $24.3M | 2026-04-09 | CEO卖出, 董事卖出 |
| ★★★★★(48) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 93,800 | $177.58 | $16.7M | 2026-08-12 | CFO卖出, 董事卖出 |
| ★★★★★(48) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 100,000 | $178.73 | $17.9M | 2026-04-09 | CFO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 6,090 | $195.62 | $1.2M | 2026-09-08 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 6,058 | $196.54 | $1.2M | 2026-09-08 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 8,752 | $197.36 | $1.7M | 2026-09-08 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 8,111 | $193.13 | $1.6M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 7,800 | $186.32 | $1.5M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 8,955 | $189.34 | $1.7M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 6,252 | $184.52 | $1.2M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 11,080 | $191.15 | $2.1M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 6,200 | $187.25 | $1.2M | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(38) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 6,200 | $191.09 | $1.2M | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 2,700 | $198.09 | $535K | 2026-09-08 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 3,045 | $188.26 | $573K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 4,593 | $185.34 | $851K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 4,955 | $183.30 | $908K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 3,413 | $182.50 | $623K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 4,209 | $192.54 | $810K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 3,500 | $181.33 | $635K | 2026-04-09 | CEO卖出, 董事卖出 |
| ★★★★★(35) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 3,000 | $182.40 | $547K | 2026-04-09 | CEO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 4,120 | $195.60 | $806K | 2026-09-08 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 4,605 | $197.23 | $908K | 2026-09-08 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 2,562 | $198.05 | $507K | 2026-09-08 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 4,475 | $196.47 | $879K | 2026-09-08 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 3,398 | $192.40 | $654K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 3,900 | $187.16 | $730K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 4,600 | $186.35 | $857K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 3,569 | $184.57 | $659K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 4,602 | $193.12 | $889K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 3,872 | $185.28 | $717K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(33) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 3,759 | $183.27 | $689K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(31) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 4,861 | $145.43 | $707K | 2026-06-18 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 2,400 | $194.33 | $466K | 2026-09-08 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 2,635 | $180.29 | $475K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 2,587 | $181.24 | $469K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 600 | $190.39 | $114K | 2026-09-04 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 223 | $180.57 | $40K | 2026-08-12 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 142 | $180.00 | $26K | 2026-08-12 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 200 | $183.00 | $37K | 2026-04-09 | CEO卖出, 董事卖出 |
| ★★★★★(30) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 2,500 | $180.36 | $451K | 2026-04-09 | CEO卖出, 董事卖出 |
| ★★★★★(30) | CHEN WAN-SHAN | - | 卖出 | 10,196 | $217.76 | $2.2M | 2026-04-09 | 董事卖出, 百万级卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 2,200 | $194.28 | $427K | 2026-09-08 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 1,800 | $190.63 | $343K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 1,900 | $188.59 | $358K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 1,633 | $180.16 | $294K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 2,000 | $182.49 | $365K | 2026-09-04 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 144 | $180.00 | $26K | 2026-08-12 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 223 | $180.57 | $40K | 2026-08-12 | CFO卖出, 董事卖出 |
| ★★★★★(28) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 10,000 | $148.34 | $1.5M | 2026-06-18 | 高管卖出, 百万级卖出 |
| ★★★★★(28) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 10,000 | $144.24 | $1.4M | 2026-06-16 | 高管卖出, 百万级卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 2,000 | $180.35 | $361K | 2026-04-09 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 1,909 | $182.58 | $349K | 2026-04-09 | CFO卖出, 董事卖出 |
| ★★★★★(28) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 291 | $183.08 | $53K | 2026-04-09 | CFO卖出, 董事卖出 |
| ★★★★★(23) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 3,748 | $144.66 | $542K | 2026-06-18 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(23) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 9 | $155.25 | $1K | 2026-05-07 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 428 | $153.56 | $66K | 2026-05-07 | 高管卖出, 减持超50%持仓 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 96 | $147.11 | $14K | 2026-06-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 1,199 | $146.24 | $175K | 2026-06-18 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 1,897 | $143.55 | $272K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 3,140 | $139.57 | $438K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 540 | $140.58 | $76K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 784 | $138.18 | $108K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 450 | $142.20 | $64K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 2,054 | $137.61 | $283K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 100 | $141.83 | $14K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 1,035 | $145.02 | $150K | 2026-06-16 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 16,666 | $171.93 | $2.9M | 2026-04-15 | 高管卖出, 百万级卖出 |
| ★★★★★(16) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 226 | $152.45 | $34K | 2026-05-07 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 3 | $154.61 | $464 | 2026-05-07 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 424 | $152.67 | $65K | 2026-05-06 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 240 | $154.41 | $37K | 2026-05-06 | 高管卖出, 减持超20%持仓 |
| ★★★★★(13) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 4,000 | $169.82 | $679K | 2026-10-01 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(10) | CHEN WAN-SHAN | - | 卖出 | 1,100 | $180.43 | $198K | 2026-04-09 | 董事卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 50 | $166.44 | $8K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 2 | $170.02 | $340 | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 78 | $167.59 | $13K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 120 | $165.49 | $20K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 12 | $168.21 | $2K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 14 | $169.36 | $2K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 24 | $164.64 | $4K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 200 | $163.63 | $33K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 8 | $151.57 | $1K | 2026-05-06 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 100 | $155.97 | $16K | 2026-05-06 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 128 | $153.42 | $20K | 2026-05-06 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 155 | $157.29 | $24K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 68 | $158.11 | $11K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 121 | $156.53 | $19K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 120 | $153.92 | $18K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 173 | $155.48 | $27K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 363 | $154.44 | $56K | 2026-05-05 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 325 | $155.21 | $50K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 172 | $157.49 | $27K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 235 | $156.57 | $37K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 236 | $154.24 | $36K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 32 | $153.50 | $5K | 2026-05-04 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 346 | $155.48 | $54K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 106 | $157.45 | $17K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 65 | $158.35 | $10K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 23 | $160.00 | $4K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 52 | $153.89 | $8K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 38 | $159.08 | $6K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 288 | $154.38 | $44K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 82 | $156.24 | $13K | 2026-05-01 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 42 | $155.68 | $7K | 2026-04-30 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 101 | $158.15 | $16K | 2026-04-30 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 340 | $157.37 | $54K | 2026-04-30 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 517 | $156.59 | $81K | 2026-04-30 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 278 | $154.58 | $43K | 2026-04-29 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 259 | $155.52 | $40K | 2026-04-29 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 339 | $156.43 | $53K | 2026-04-29 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 22 | $158.19 | $3K | 2026-04-29 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 102 | $157.39 | $16K | 2026-04-29 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 53 | $156.61 | $8K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 8 | $155.36 | $1K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 120 | $160.27 | $19K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 380 | $159.42 | $61K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 12 | $154.65 | $2K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 222 | $157.49 | $35K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 54 | $162.14 | $9K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 62 | $158.71 | $10K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 89 | $161.72 | $14K | 2026-04-28 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 280 | $161.62 | $45K | 2026-04-27 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 409 | $163.56 | $67K | 2026-04-27 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 44 | $160.83 | $7K | 2026-04-27 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 36 | $164.07 | $6K | 2026-04-27 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 231 | $162.38 | $38K | 2026-04-27 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 375 | $159.46 | $60K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 74 | $157.86 | $12K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 3 | $162.53 | $488 | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 28 | $161.22 | $5K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 330 | $160.40 | $53K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 190 | $158.65 | $30K | 2026-04-24 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 267 | $164.47 | $44K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 158 | $165.38 | $26K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 21 | $169.56 | $4K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 127 | $166.56 | $21K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 54 | $168.43 | $9K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 373 | $167.37 | $62K | 2026-04-23 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 141 | $167.42 | $24K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 105 | $169.52 | $18K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 249 | $172.49 | $43K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 257 | $171.62 | $44K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 31 | $165.70 | $5K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 101 | $168.64 | $17K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 21 | $173.04 | $4K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 75 | $170.58 | $13K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 20 | $166.32 | $3K | 2026-04-22 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 332 | $165.49 | $55K | 2026-04-21 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 214 | $167.34 | $36K | 2026-04-21 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 78 | $164.60 | $13K | 2026-04-21 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 312 | $166.49 | $52K | 2026-04-21 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 64 | $163.49 | $10K | 2026-04-21 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 284 | $162.76 | $46K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 3 | $166.91 | $501 | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 124 | $164.40 | $20K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 524 | $163.52 | $86K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 16 | $167.17 | $3K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 9 | $168.35 | $2K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 40 | $165.29 | $7K | 2026-04-20 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 200 | $163.33 | $33K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 226 | $160.55 | $36K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 32 | $158.46 | $5K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 216 | $162.48 | $35K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 52 | $159.38 | $8K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 274 | $161.41 | $44K | 2026-04-17 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 201 | $160.35 | $32K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 36 | $163.21 | $6K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 76 | $162.26 | $12K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 240 | $161.61 | $39K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 216 | $158.28 | $34K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 12 | $164.12 | $2K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 219 | $159.81 | $35K | 2026-04-16 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 537 | $168.64 | $91K | 2026-04-15 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 8 | $170.77 | $1K | 2026-04-15 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 4 | $171.19 | $685 | 2026-04-15 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 68 | $169.15 | $12K | 2026-04-15 | 高管卖出 |
| ★★★★★(8) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 383 | $167.58 | $64K | 2026-04-15 | 高管卖出 |
| ★★★★★(0) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 10,000 | - | - | 2026-04-21 | |
| ★★★★★(0) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 10,000 | - | - | 2026-04-21 | |
| ★★★★★(0) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 10,000 | - | - | 2026-04-21 | |
| ★★★★★(0) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 144,868 | - | - | 2026-03-31 | |
| ★★★★★(0) | CHEN WAN-SHAN | - | 卖出 | 13,796 | - | - | 2026-03-31 | |
| ★★★★★(0) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 206,954 | - | - | 2026-03-31 | |
| ★★★★★(0) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 144,868 | - | - | 2026-03-31 | |
| ★★★★★(0) | CHEN XIAO-HUI | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LU ITA | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LIN YU-HSIN | Chief Executive Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | BIDDLE GARY CLARK | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | CHUANG HAO-YUAN | Chief Financial Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | LONGO JOHN MICHAEL | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | SCHOLL HENDRIK PETER | Chief Medical Officer | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | CHEN WAN-SHAN | - | 卖出 | 0 | - | - | 2026-03-18 | |
| ★★★★★(0) | MATA NATHAN L. | Chief Scientific Officer | 卖出 | 0 | - | - | 2026-03-18 |